Insights on the Artificial Intelligence in Digital Genome Global Market to 2028 - by Offering, Technology, Functionality, Application, End-user, and Region
18 avr. 2022 07h48 HE
|
Research and Markets
Dublin, April 18, 2022 (GLOBE NEWSWIRE) -- The "Artificial Intelligence in Digital Genome Market, by Offering, by Technology, by Functionality, by Application, by End User, and by Region - Size,...
Global Genetic Testing Markets Forecasts, Applications and Technologies Report 2022-2027: Explosion in Genetic Knowledge Creates New Global Market for Diagnostics
18 avr. 2022 04h48 HE
|
Research and Markets
Dublin, April 18, 2022 (GLOBE NEWSWIRE) -- The "Genetic Testing. Global Market Forecasts for Applications and Technologies. Updated for COVID-19 Pandemic impact With Executive and Consultant Guides"...
Praxis Precision Medicines to Host Epilepsy Day on April 27, 2022
13 avr. 2022 08h00 HE
|
Praxis Precision Medicines, Inc.
BOSTON, April 13, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
Kura Oncology Reports Preclinical Data Supporting Use of Tipifarnib to Prevent Emergence of Resistance to Osimertinib in Non-Small Cell Lung Cancer
08 avr. 2022 13h00 HE
|
Kura Oncology, Inc.
– Late-breaking presentation at AACR demonstrates potential to significantly delay onset of drug resistance to EGFR-targeted therapies through combination with a farnesyl transferase inhibitor – –...
Global Oncology Precision Medicine Market to 2031 - Focus on Ecosystem and Application
30 mars 2022 05h08 HE
|
Research and Markets
Dublin, March 30, 2022 (GLOBE NEWSWIRE) -- The "Oncology Precision Medicine Market - A Global and Regional Analysis: Focus on Ecosystem and Application - Analysis and Forecast, 2020-2031" report has...
Precision Medicine Software Developers Market, 2031
30 mars 2022 04h38 HE
|
Research and Markets
Dublin, March 30, 2022 (GLOBE NEWSWIRE) -- The "Precision Medicine Software Developers Market by Target Therapeutic Indication, Key Geographical Regions and Types of End Users: Industry Trends and...
InnoSIGN schließt den Spin-off von Philips mit einer Serie A-Finanzierung in Höhe von 8 Mio. USD ab, um die Präzisionsmedizin durch seine OncoSIGNal Pathway Activity Profiling Plattform zu revolutionieren
22 mars 2022 09h00 HE
|
InnoSIGN
InnoSIGN nutzt seine firmeneigene Datenbank mit über 100.000 Aktivitätsprofilen von Signalwegen für die Arzneimittelentwicklung und Diagnostik, um das Ansprechen von Patienten auf zielgerichtete...
InnoSIGN se sépare de Philips au moyen d'un financement de série A de 8 millions USD pour révolutionner la médecine de précision via sa plateforme de profilage de l'activité des voies cellulaires OncoSIGNal
22 mars 2022 09h00 HE
|
InnoSIGN
InnoSIGN emploie sa base de données exclusive contenant plus de 100 000 profils d'activité des voies cellulaires, pour le développement de médicaments et pour les diagnostics afin de prédire la...
InnoSIGN Completes Spin-Out from Philips with an $8M Series A Financing to Revolutionize Precision Medicine through its OncoSIGNal Pathway Activity Profiling Platform
22 mars 2022 09h00 HE
|
InnoSIGN
InnoSIGN utilizes its proprietary database with over 100,000 pathway activity profiles for drug development and diagnostics to predict patient response to targeted therapies Proceeds support...
Global Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Analysis
16 mars 2022 07h58 HE
|
Research and Markets
Dublin, March 16, 2022 (GLOBE NEWSWIRE) -- The "Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology, Application, and End User" report has been added to...